Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-08-01

AUTHORS

Kimihisa Ichikawa, Weimin Liu, Limin Zhao, Zheng Wang, Di Liu, Toshiaki Ohtsuka, Huangge Zhang, John D. Mountz, William J. Koopman, Robert P. Kimberly, Tong Zhou

ABSTRACT

A novel anti-human DR5 monoclonal antibody, TRA-8, induces apoptosis of most tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-sensitive tumor cells both in vitro and in vivo. In contrast to both the membrane-bound form of human TRAIL, which induced severe hepatitis in mice, and the soluble form of human TRAIL, which induced apoptosis of normal human hepatocytes in vitro, TRA-8 did not induce significant cell death of normal human hepatocytes. However, both primary hepatocellular carcinoma cells and an established liver cancer cell line were highly susceptible to the killing mediated by TRA-8. We show here that elevated levels of cell-surface expression of DR5 and increased susceptibility to DR5-mediated apoptosis are characteristics of malignant tumor cells. In contrast, DR5 alone is not sufficient to trigger apoptosis of normal hepatocytes. Therefore, selective, specific targeting of DR5 with an agonistic antibody might be a safe and effective strategy for cancer therapy. More... »

PAGES

954-960

Journal

TITLE

Nature Medicine

ISSUE

8

VOLUME

7

Related Patents

  • Ligand Having Agonistic Activity To Mutated Receptor
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Antibody Selective For A Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor And Uses Thereof
  • Anti-Dr5 Antibodies, Polynucleotides And Methods
  • Combinations Of Dr5 Antibodies And Other Therapeutic Agents
  • Method Of Treating Cancer With A Pharmaceutical Formulation Comprising A Her2 Antibody
  • Anti-Dr5 Antibodies, Polynucleotides And Methods
  • Immunoliposome Inducing Apoptosis Into Cell Expressing Death Domain-Containing Receptor
  • Trail Receptor-2 Polypeptides And Antibodies
  • Immunotherapeutic Molecules And Uses
  • Trailr2 Cdh17 Binding Molecules For The Treatment Of Cancer
  • Combination Of Gsk3 Inhibitor And Anti-Dr5 Antibody
  • Immunoliposome Inducing Apoptosis Into Cell Expressing Death Domain-Containing Receptor
  • Antibody Modified With Hydrophobic Molecule
  • Anti-Mpl Antibodies
  • Anti-Trail-R Antibodies
  • Tumor Necrosis Factor (Tnf) Superfamily Receptor Igm Antibodies And Uses Thereof
  • Antibody Selective For A Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor And Uses Thereof
  • Structural Isomers Of Sc(Fv)2
  • Antibody Selective For A Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor And Uses Thereof
  • Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents
  • Treating Basal-Like Genotype Cancers
  • Dr5 Antibodies And Articles Of Manufacture Containing Same
  • Agents And Methods Related To Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
  • Agents And Methods Related To Screening For Resistance To Dr5 And Reducing Resistance To Dr5 Agonists
  • Treating Basal-Like Genotype Cancers
  • Antibody Formulations
  • Targeting Cancer Stem Cells With Dr5 Agonists
  • Anti-Dr5 Antibodies And Methods Of Use Thereof
  • Pharmaceutical Compositions Containing Sc(Fv)2
  • Assays And Methods Using Biomarkers
  • Re-Directed Immunotherapy
  • Agents And Methods Related To Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
  • Multimeric Death Domain-Containing Receptor-5 (Dr5) Antibodies And Uses Thereof
  • Antibody Selective For A Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Dr5 And Uses Thereof
  • Biomarkers For Cancer Sensitivity And Uses Thereof
  • Assays And Methods Using Biomarkers
  • Antibody Selective For A Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor And Uses Thereof
  • Anti-Mpl Antibodies
  • Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents
  • Trail Receptor-Binding Agents And Uses Of The Same
  • Antibody Specifically Binding To Dr5 And Composition For Preventing Or Treating Cancers Comprising The Same
  • Biomarkers For Cancer Sensitivity And Uses Thereof
  • Multispecific Gitr-Binding Fusion Proteins And Methods Of Use Thereof
  • Antibody Modified With Hydrophobic Molecule
  • Cell Death-Inducing Agent
  • Multivalent Molecules Comprising Dr5-Binding Domains
  • Antibody Selective For A Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor And Uses Thereof
  • Stabilizer For Protein Preparation Comprising Meglumine And Use Thereof
  • Multivalent And Multispecific Glucocorticoid-Induced Tnfr-Related Protein (Gitr)-Binding Single-Domain Antibody Fusion Proteins And Encoding Nucleic Acids
  • Antibody Selective For Dr4 And Uses Thereof
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/91000

    DOI

    http://dx.doi.org/10.1038/91000

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1047281881

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/11479629


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis Regulatory Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Primers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glioma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hepatocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred BALB C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, TNF-Related Apoptosis-Inducing Ligand", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Tumor Necrosis Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reverse Transcriptase Polymerase Chain Reaction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "TNF-Related Apoptosis-Inducing Ligand", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Necrosis Factor-alpha", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Biomedical Research Laboratories, Sankyo Co., Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.410844.d", 
              "name": [
                "Biomedical Research Laboratories, Sankyo Co., Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ichikawa", 
            "givenName": "Kimihisa", 
            "id": "sg:person.01224712213.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224712213.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "Weimin", 
            "id": "sg:person.0766610717.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766610717.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhao", 
            "givenName": "Limin", 
            "id": "sg:person.01034724117.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034724117.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "Zheng", 
            "id": "sg:person.01117126520.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117126520.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liu", 
            "givenName": "Di", 
            "id": "sg:person.01014130742.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014130742.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Biomedical Research Laboratories, Sankyo Co., Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.410844.d", 
              "name": [
                "Biomedical Research Laboratories, Sankyo Co., Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ohtsuka", 
            "givenName": "Toshiaki", 
            "id": "sg:person.01217265717.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217265717.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhang", 
            "givenName": "Huangge", 
            "id": "sg:person.01054374560.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054374560.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mountz", 
            "givenName": "John D.", 
            "id": "sg:person.016504134024.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016504134024.86"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Koopman", 
            "givenName": "William J.", 
            "id": "sg:person.0710476716.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710476716.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kimberly", 
            "givenName": "Robert P.", 
            "id": "sg:person.01304356355.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304356355.83"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhou", 
            "givenName": "Tong", 
            "id": "sg:person.0664616100.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/75045", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044338034", 
              "https://doi.org/10.1038/75045"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/5517", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010598958", 
              "https://doi.org/10.1038/5517"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/86397", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004368073", 
              "https://doi.org/10.1038/86397"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cdd.4400467", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015301816", 
              "https://doi.org/10.1038/sj.cdd.4400467"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35008667", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012881410", 
              "https://doi.org/10.1038/35008667"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2001-08-01", 
        "datePublishedReg": "2001-08-01", 
        "description": "A novel anti-human DR5 monoclonal antibody, TRA-8, induces apoptosis of most tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-sensitive tumor cells both in vitro and in vivo. In contrast to both the membrane-bound form of human TRAIL, which induced severe hepatitis in mice, and the soluble form of human TRAIL, which induced apoptosis of normal human hepatocytes in vitro, TRA-8 did not induce significant cell death of normal human hepatocytes. However, both primary hepatocellular carcinoma cells and an established liver cancer cell line were highly susceptible to the killing mediated by TRA-8. We show here that elevated levels of cell-surface expression of DR5 and increased susceptibility to DR5-mediated apoptosis are characteristics of malignant tumor cells. In contrast, DR5 alone is not sufficient to trigger apoptosis of normal hepatocytes. Therefore, selective, specific targeting of DR5 with an agonistic antibody might be a safe and effective strategy for cancer therapy.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/91000", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2567549", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1113716", 
            "issn": [
              "1078-8956", 
              "1546-170X"
            ], 
            "name": "Nature Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "8", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "7"
          }
        ], 
        "keywords": [
          "TRA-8", 
          "normal human hepatocytes", 
          "tumor cells", 
          "monoclonal antibodies", 
          "human hepatocytes", 
          "tumor necrosis factor-related apoptosis-inducing ligand", 
          "necrosis factor-related apoptosis-inducing ligand", 
          "factor-related apoptosis-inducing ligand", 
          "liver cancer cell lines", 
          "sensitive tumor cells", 
          "primary hepatocellular carcinoma cells", 
          "human TRAIL", 
          "malignant tumor cells", 
          "apoptosis-inducing ligand", 
          "cancer cell lines", 
          "severe hepatitis", 
          "hepatocellular carcinoma cells", 
          "cell surface expression", 
          "agonistic antibodies", 
          "tumoricidal activity", 
          "significant cell death", 
          "carcinoma cells", 
          "elevated levels", 
          "cancer therapy", 
          "hepatocyte cytotoxicity", 
          "antibodies", 
          "normal hepatocytes", 
          "cell lines", 
          "DR5", 
          "specific targeting", 
          "apoptosis", 
          "cell death", 
          "hepatocytes", 
          "soluble form", 
          "cells", 
          "effective strategy", 
          "hepatitis", 
          "therapy", 
          "mice", 
          "death", 
          "membrane-bound form", 
          "vivo", 
          "cytotoxicity", 
          "killing", 
          "contrast", 
          "targeting", 
          "expression", 
          "susceptibility", 
          "trails", 
          "levels", 
          "activity", 
          "strategies", 
          "lines", 
          "form", 
          "ligands", 
          "characteristics"
        ], 
        "name": "Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity", 
        "pagination": "954-960", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1047281881"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/91000"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "11479629"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/91000", 
          "https://app.dimensions.ai/details/publication/pub.1047281881"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:21", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_321.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/91000"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/91000'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/91000'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/91000'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/91000'


     

    This table displays all metadata directly associated to this object as RDF triples.

    293 TRIPLES      22 PREDICATES      107 URIs      94 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/91000 schema:about N03f967de2fa94874ae543ab3191d673e
    2 N1757eb2abeca41ad92306981e8ddd742
    3 N1cd0fe98404e49a08c8f49b67313c278
    4 N23ced5d359ae4f9287d16fb7251312d0
    5 N36fad8a429664b63a4c5e3539a7de0e1
    6 N3d64c7670dc5447d93d81f627013590a
    7 N44a7d1486db74a698dfaa356218cff78
    8 N4fa31b86aabd4bc8a6c67d0a71fd8d52
    9 N864d0ecdb51d49a1b8ae6dea97acb3b5
    10 Naca4ad39ef574ee6bb291efa861e6f83
    11 Naf515f6f96c9492fae4413a7aa93612d
    12 Nb0d4a585f32a488980039d2a046d10bd
    13 Nb2a32d95ff2540f08aa84a82d27c789f
    14 Nb871a95ccf5d40fcbaece97a0d69b0f0
    15 Nd0e1beaeffc9479cb04a10510b76916f
    16 Nd85578fa18c540c2b902eafe6117a3ab
    17 Ne0381f1a824c43e1b34c87632ba45c2d
    18 Nea33cf4fc8b24337817e05b3ac0b9546
    19 Nf925203476f549dba3e63bb977b4c0c4
    20 Nfc686cf16d21482c884db670042854d8
    21 anzsrc-for:11
    22 anzsrc-for:1112
    23 schema:author N687d2746fac84834a7b8bb39f483ab38
    24 schema:citation sg:pub.10.1038/35008667
    25 sg:pub.10.1038/5517
    26 sg:pub.10.1038/75045
    27 sg:pub.10.1038/86397
    28 sg:pub.10.1038/sj.cdd.4400467
    29 schema:datePublished 2001-08-01
    30 schema:datePublishedReg 2001-08-01
    31 schema:description A novel anti-human DR5 monoclonal antibody, TRA-8, induces apoptosis of most tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-sensitive tumor cells both in vitro and in vivo. In contrast to both the membrane-bound form of human TRAIL, which induced severe hepatitis in mice, and the soluble form of human TRAIL, which induced apoptosis of normal human hepatocytes in vitro, TRA-8 did not induce significant cell death of normal human hepatocytes. However, both primary hepatocellular carcinoma cells and an established liver cancer cell line were highly susceptible to the killing mediated by TRA-8. We show here that elevated levels of cell-surface expression of DR5 and increased susceptibility to DR5-mediated apoptosis are characteristics of malignant tumor cells. In contrast, DR5 alone is not sufficient to trigger apoptosis of normal hepatocytes. Therefore, selective, specific targeting of DR5 with an agonistic antibody might be a safe and effective strategy for cancer therapy.
    32 schema:genre article
    33 schema:inLanguage en
    34 schema:isAccessibleForFree false
    35 schema:isPartOf Ndbbc7e91cc5e4e20a8458696f9596dd9
    36 Nfbf84cd5c8864f259e8a38cd88d85ef7
    37 sg:journal.1113716
    38 schema:keywords DR5
    39 TRA-8
    40 activity
    41 agonistic antibodies
    42 antibodies
    43 apoptosis
    44 apoptosis-inducing ligand
    45 cancer cell lines
    46 cancer therapy
    47 carcinoma cells
    48 cell death
    49 cell lines
    50 cell surface expression
    51 cells
    52 characteristics
    53 contrast
    54 cytotoxicity
    55 death
    56 effective strategy
    57 elevated levels
    58 expression
    59 factor-related apoptosis-inducing ligand
    60 form
    61 hepatitis
    62 hepatocellular carcinoma cells
    63 hepatocyte cytotoxicity
    64 hepatocytes
    65 human TRAIL
    66 human hepatocytes
    67 killing
    68 levels
    69 ligands
    70 lines
    71 liver cancer cell lines
    72 malignant tumor cells
    73 membrane-bound form
    74 mice
    75 monoclonal antibodies
    76 necrosis factor-related apoptosis-inducing ligand
    77 normal hepatocytes
    78 normal human hepatocytes
    79 primary hepatocellular carcinoma cells
    80 sensitive tumor cells
    81 severe hepatitis
    82 significant cell death
    83 soluble form
    84 specific targeting
    85 strategies
    86 susceptibility
    87 targeting
    88 therapy
    89 trails
    90 tumor cells
    91 tumor necrosis factor-related apoptosis-inducing ligand
    92 tumoricidal activity
    93 vivo
    94 schema:name Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
    95 schema:pagination 954-960
    96 schema:productId N09f53c690f54411288b1b71f78b90aac
    97 Nb2d8c9fe200f4577be24b3fd807c02ef
    98 Ne2698fb186ab47c98336126211eb6a2e
    99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047281881
    100 https://doi.org/10.1038/91000
    101 schema:sdDatePublished 2022-05-20T07:21
    102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    103 schema:sdPublisher N404d913ea35b4ec190997764f3b114a2
    104 schema:url https://doi.org/10.1038/91000
    105 sgo:license sg:explorer/license/
    106 sgo:sdDataset articles
    107 rdf:type schema:ScholarlyArticle
    108 N03f967de2fa94874ae543ab3191d673e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Humans
    110 rdf:type schema:DefinedTerm
    111 N09f53c690f54411288b1b71f78b90aac schema:name pubmed_id
    112 schema:value 11479629
    113 rdf:type schema:PropertyValue
    114 N0e466b47c1a945349a842a2638ee4990 rdf:first sg:person.01217265717.13
    115 rdf:rest Nffa350e5abe640ceb03dd8d80c372c6b
    116 N1757eb2abeca41ad92306981e8ddd742 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name TNF-Related Apoptosis-Inducing Ligand
    118 rdf:type schema:DefinedTerm
    119 N1cd0fe98404e49a08c8f49b67313c278 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Brain Neoplasms
    121 rdf:type schema:DefinedTerm
    122 N23ced5d359ae4f9287d16fb7251312d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Glioma
    124 rdf:type schema:DefinedTerm
    125 N2a138c53c810414b8fae11a80553417f rdf:first sg:person.016504134024.86
    126 rdf:rest Na397b8db5e5b44dd9ea2047db5b6b804
    127 N36fad8a429664b63a4c5e3539a7de0e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Apoptosis Regulatory Proteins
    129 rdf:type schema:DefinedTerm
    130 N3d64c7670dc5447d93d81f627013590a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Mice, Inbred BALB C
    132 rdf:type schema:DefinedTerm
    133 N404d913ea35b4ec190997764f3b114a2 schema:name Springer Nature - SN SciGraph project
    134 rdf:type schema:Organization
    135 N439c9c910f1d4accba9e28e0ed202603 rdf:first sg:person.01117126520.59
    136 rdf:rest N7ae7425ff3344332acc7e0472a3787fd
    137 N44a7d1486db74a698dfaa356218cff78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Membrane Glycoproteins
    139 rdf:type schema:DefinedTerm
    140 N4fa31b86aabd4bc8a6c67d0a71fd8d52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Receptors, TNF-Related Apoptosis-Inducing Ligand
    142 rdf:type schema:DefinedTerm
    143 N687d2746fac84834a7b8bb39f483ab38 rdf:first sg:person.01224712213.44
    144 rdf:rest Na2e649afb56245479904e5b18e0edff6
    145 N6f55a4f1d43549899773fa3c2cfa6fc6 rdf:first sg:person.01304356355.83
    146 rdf:rest Na02660093d45479885b8f8bd74d8e87d
    147 N7ae7425ff3344332acc7e0472a3787fd rdf:first sg:person.01014130742.19
    148 rdf:rest N0e466b47c1a945349a842a2638ee4990
    149 N864d0ecdb51d49a1b8ae6dea97acb3b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name DNA Primers
    151 rdf:type schema:DefinedTerm
    152 Na02660093d45479885b8f8bd74d8e87d rdf:first sg:person.0664616100.38
    153 rdf:rest rdf:nil
    154 Na2e649afb56245479904e5b18e0edff6 rdf:first sg:person.0766610717.99
    155 rdf:rest Nc8f1b8039eab4ce6b137455f97c9b679
    156 Na397b8db5e5b44dd9ea2047db5b6b804 rdf:first sg:person.0710476716.33
    157 rdf:rest N6f55a4f1d43549899773fa3c2cfa6fc6
    158 Naca4ad39ef574ee6bb291efa861e6f83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Animals
    160 rdf:type schema:DefinedTerm
    161 Naf515f6f96c9492fae4413a7aa93612d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Apoptosis
    163 rdf:type schema:DefinedTerm
    164 Nb0d4a585f32a488980039d2a046d10bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Base Sequence
    166 rdf:type schema:DefinedTerm
    167 Nb2a32d95ff2540f08aa84a82d27c789f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Tumor Cells, Cultured
    169 rdf:type schema:DefinedTerm
    170 Nb2d8c9fe200f4577be24b3fd807c02ef schema:name dimensions_id
    171 schema:value pub.1047281881
    172 rdf:type schema:PropertyValue
    173 Nb871a95ccf5d40fcbaece97a0d69b0f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Mice
    175 rdf:type schema:DefinedTerm
    176 Nc8f1b8039eab4ce6b137455f97c9b679 rdf:first sg:person.01034724117.18
    177 rdf:rest N439c9c910f1d4accba9e28e0ed202603
    178 Nd0e1beaeffc9479cb04a10510b76916f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Hepatocytes
    180 rdf:type schema:DefinedTerm
    181 Nd85578fa18c540c2b902eafe6117a3ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Reverse Transcriptase Polymerase Chain Reaction
    183 rdf:type schema:DefinedTerm
    184 Ndbbc7e91cc5e4e20a8458696f9596dd9 schema:issueNumber 8
    185 rdf:type schema:PublicationIssue
    186 Ne0381f1a824c43e1b34c87632ba45c2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Tumor Necrosis Factor-alpha
    188 rdf:type schema:DefinedTerm
    189 Ne2698fb186ab47c98336126211eb6a2e schema:name doi
    190 schema:value 10.1038/91000
    191 rdf:type schema:PropertyValue
    192 Nea33cf4fc8b24337817e05b3ac0b9546 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Receptors, Tumor Necrosis Factor
    194 rdf:type schema:DefinedTerm
    195 Nf925203476f549dba3e63bb977b4c0c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Antibodies, Monoclonal
    197 rdf:type schema:DefinedTerm
    198 Nfbf84cd5c8864f259e8a38cd88d85ef7 schema:volumeNumber 7
    199 rdf:type schema:PublicationVolume
    200 Nfc686cf16d21482c884db670042854d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Female
    202 rdf:type schema:DefinedTerm
    203 Nffa350e5abe640ceb03dd8d80c372c6b rdf:first sg:person.01054374560.30
    204 rdf:rest N2a138c53c810414b8fae11a80553417f
    205 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    206 schema:name Medical and Health Sciences
    207 rdf:type schema:DefinedTerm
    208 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    209 schema:name Oncology and Carcinogenesis
    210 rdf:type schema:DefinedTerm
    211 sg:grant.2567549 http://pending.schema.org/fundedItem sg:pub.10.1038/91000
    212 rdf:type schema:MonetaryGrant
    213 sg:journal.1113716 schema:issn 1078-8956
    214 1546-170X
    215 schema:name Nature Medicine
    216 schema:publisher Springer Nature
    217 rdf:type schema:Periodical
    218 sg:person.01014130742.19 schema:affiliation grid-institutes:grid.265892.2
    219 schema:familyName Liu
    220 schema:givenName Di
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014130742.19
    222 rdf:type schema:Person
    223 sg:person.01034724117.18 schema:affiliation grid-institutes:grid.265892.2
    224 schema:familyName Zhao
    225 schema:givenName Limin
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034724117.18
    227 rdf:type schema:Person
    228 sg:person.01054374560.30 schema:affiliation grid-institutes:grid.265892.2
    229 schema:familyName Zhang
    230 schema:givenName Huangge
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054374560.30
    232 rdf:type schema:Person
    233 sg:person.01117126520.59 schema:affiliation grid-institutes:grid.265892.2
    234 schema:familyName Wang
    235 schema:givenName Zheng
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117126520.59
    237 rdf:type schema:Person
    238 sg:person.01217265717.13 schema:affiliation grid-institutes:grid.410844.d
    239 schema:familyName Ohtsuka
    240 schema:givenName Toshiaki
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217265717.13
    242 rdf:type schema:Person
    243 sg:person.01224712213.44 schema:affiliation grid-institutes:grid.410844.d
    244 schema:familyName Ichikawa
    245 schema:givenName Kimihisa
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224712213.44
    247 rdf:type schema:Person
    248 sg:person.01304356355.83 schema:affiliation grid-institutes:grid.265892.2
    249 schema:familyName Kimberly
    250 schema:givenName Robert P.
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304356355.83
    252 rdf:type schema:Person
    253 sg:person.016504134024.86 schema:affiliation grid-institutes:grid.265892.2
    254 schema:familyName Mountz
    255 schema:givenName John D.
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016504134024.86
    257 rdf:type schema:Person
    258 sg:person.0664616100.38 schema:affiliation grid-institutes:grid.265892.2
    259 schema:familyName Zhou
    260 schema:givenName Tong
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664616100.38
    262 rdf:type schema:Person
    263 sg:person.0710476716.33 schema:affiliation grid-institutes:grid.265892.2
    264 schema:familyName Koopman
    265 schema:givenName William J.
    266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710476716.33
    267 rdf:type schema:Person
    268 sg:person.0766610717.99 schema:affiliation grid-institutes:grid.265892.2
    269 schema:familyName Liu
    270 schema:givenName Weimin
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766610717.99
    272 rdf:type schema:Person
    273 sg:pub.10.1038/35008667 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012881410
    274 https://doi.org/10.1038/35008667
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1038/5517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010598958
    277 https://doi.org/10.1038/5517
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1038/75045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044338034
    280 https://doi.org/10.1038/75045
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1038/86397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004368073
    283 https://doi.org/10.1038/86397
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1038/sj.cdd.4400467 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015301816
    286 https://doi.org/10.1038/sj.cdd.4400467
    287 rdf:type schema:CreativeWork
    288 grid-institutes:grid.265892.2 schema:alternateName Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    289 schema:name Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    290 rdf:type schema:Organization
    291 grid-institutes:grid.410844.d schema:alternateName Biomedical Research Laboratories, Sankyo Co., Tokyo, Japan
    292 schema:name Biomedical Research Laboratories, Sankyo Co., Tokyo, Japan
    293 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...